Targeting pepsin provides superior protection to acid suppression in reflux‐associated airway inflammation and lung dysfunction
Experimental Physiology · 05.11.2026
DOI: 10.1113/ep093251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Physiology, online erschienen am 05.11.2026. Verfasst von Thiago Meneses Araújo Leite Sales und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Estácio University Center of Ceará, Fortaleza, Ceará, Brazil. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ceará Foundation for Scientific and Technological Development Support (FUNCAP), National Council for Scientific and Technological Development (CNPq).
Abstract (Originalsprache)
Gastro‐oesophageal reflux disease is a prevalent condition associated with extra‐oesophageal manifestations, such as pulmonary inflammation. Pepsin, an essential gastric enzyme, has been implicated in pulmonary complications owing to its inflammatory effects. Although acid‐suppressive therapies, such as proton pump inhibitors, reduce gastric acidity, they do not prevent reflux episodes, microaspiration or the harmful effects of pepsin. This study evaluated the effects of pepsin inhibition by pepstatin on inflammation and pulmonary dysfunction in a murine model of reflux. Male Swiss mice were anaesthetized with ketamine and xylazine and subjected to a surgical procedure involving pyloric stenosis and complete stenosis of the gastric fundus to induce reflux. The mice were divided into four groups: sham, reflux, reflux + pepstatin and reflux + omeprazole. Treatments were administered daily for 28 days. The evaluated parameters included oesophageal and pulmonary wet weights, myeloperoxidase activity, cytokine levels [interleukin (IL)‐6, IL‐10 and keratinocyte chemoattractant], histopathological alveolitis scores, functional analyses of spirometry and tracheal contractility. The reflux group exhibited significant oesophageal and pulmonary oedema, increased myeloperoxidase activity, elevated levels of IL‐6 and keratinocyte chemoattractant, reduced IL‐10, severe alveolitis, impaired pulmonary function and tracheal hyper‐reactivity. Pepstatin treatment significantly reduced inflammatory and functional alterations in the reflux model. In contrast, omeprazole was less effective at controlling inflammation and improving pulmonary function. These findings suggest that pepsin inhibition might reduce pulmonary inflammation and help to preserve lung function in a murine reflux model. Targeting pepsin, rather than solely suppressing gastric acidity, shows promise in mitigating reflux‐related extra‐oesophageal complications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, Estácio University Center of Ceará, Fortaleza, Ceará, Brazil.
- Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.
- Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.
- Laboratory of Inflammation and Translational Gastroenterology (LIGAT), Federal University of Delta do Parnaíba, Parnaíba, Piauí, Brazil.
- Department of Morphology, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.
- Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
ORCID-Profile: Pedro Jorge Caldas Magalhães, Marcellus Henrique Loiola Ponte de Souza
Förderung
- Ceará Foundation for Scientific and Technological Development Support (FUNCAP)
- National Council for Scientific and Technological Development (CNPq)
Zitieren
APA
Sales, T. M. A. L., da Costa Filho, H. B., Gadelha, K. K. L., Nogueira, K. M., Franco, Á. X., Monteiro, C. E. D. S., de Sousa, M. K. A., Souza, M. C., Melo, I. S. S., Nicolau, L. A. D., Clementino, M. A. F., Magalhães, P. J. C., Havt, A., Soares, P. M. G., Sifrim, D., & de Souza, M. H. L. P. (2026). Targeting pepsin provides superior protection to acid suppression in reflux‐associated airway inflammation and lung dysfunction. Experimental Physiology. https://doi.org/10.1113/ep093251
Vancouver
Sales TMAL, da Costa Filho HB, Gadelha KKL, Nogueira KM, Franco ÁX, Monteiro CEDS, et al. Targeting pepsin provides superior protection to acid suppression in reflux‐associated airway inflammation and lung dysfunction. Experimental Physiology. 2026. doi:10.1113/ep093251
BibTeX
@article{Sales2026,
author = {Sales, Thiago Meneses Araújo Leite and da Costa Filho, Humberto Barbosa and Gadelha, Kalinne Kelly Lima and Nogueira, Kerolayne de Melo and Franco, Álvaro Xavier and Monteiro, Carlos Eduardo da Silva and de Sousa, Maria Klayre Araújo and Souza, Monalisa Cássias and Melo, Isabele de Sá Silveira and Nicolau, Lucas Antonio Duarte and Clementino, Marco Antonio de Freitas and Magalhães, Pedro Jorge Caldas and Havt, Alexandre and Soares, Pedro Marcos Gomes and Sifrim, Daniel and de Souza, Marcellus Henrique Loiola Ponte},
title = {Targeting pepsin provides superior protection to acid suppression in reflux‐associated airway inflammation and lung dysfunction},
journal = {Experimental Physiology},
year = {2026},
doi = {10.1113/ep093251}
}
EUVIMED